Drug intelligence / Profile preview

ONCOFUCO

Development stage
Unknown
Lead developer
Hi-Q Marine Biotech International
Administration
Oral
01

Overview

ONCOFUCO is a dietary supplement and functional ingredient developed by Hi-Q Marine Biotech International, specifically formulated for cancer supportive care. Its primary active component is OliFuco®, a proprietary low molecular weight fucoidan (oligofucoidan) extracted from the brown seaweed *Laminaria japonica*. Each 550 mg capsule contains high-purity fucoidan designed to serve as an adjunctive therapy for cancer patients. The product is intended to modulate the immune system, mitigate the side effects of chemotherapy and radiotherapy, and address cancer-related cachexia. Clinical research, including a double-blind randomized controlled trial in metastatic colorectal cancer patients, supports its use in improving patient outcomes and quality of life. ONCOFUCO has been available in the Taiwanese market for over 14 years and is utilized in hospitals and clinics, holding the Symbol of National Quality (SNQ) certification.

Brand names
ONCOFUCO
Other names
Oligo FucoidanOliFucoLow Molecular Weight FucoidanLaminaria japonica extract

Beyond the preview

Go deeper on ONCOFUCO.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ONCOFUCO.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call